US Earnings Financial Results SEC Filings — September 22, 2026

22-09-2026

Thor Industries reported fiscal 2026 net sales of $9.61B, essentially flat (+0.3%) versus $9.58B in fiscal 2025. However, gross profit declined 9.5% to $1.21B and net income before taxes fell 19.4% to $238.7M, driven by a sharp 16.1% drop in North American Towable RV sales and a 40.4% plunge in that segment's pre-tax income. Offsetting these declines, North American Motorized sales grew 12.8% and European sales rose 9.0%, though European pre-tax income still fell 28.9%.

• · North American Towable gross profit margin fell from 13.1% to 11.2%.
• · North American Motorized gross profit margin declined from 9.7% to 8.8%.
• · European gross profit margin decreased from 15.2% to 13.5%.
• · Other segment gross profit margin held steady at 20.1%.
• · Corporate expenses decreased 33.6% to $127.1M.
• · Quarterly net income ranged from $17.8M (Jan 31 quarter) to $97.2M (Apr 30 quarter).
• · Dividends paid remained constant at $0.52 per share each quarter.
• · Stock price high was $122.83 (Apr 30 quarter) and low was $69.71 (Jul 31 quarter).
• · European net sales growth of 9.0% was partly driven by a 5.9% favorable foreign currency impact; mix and price contributed 0.4%.

22-09-2026

Readvantage Corp. reported a net loss of $106,371 for FY2026, more than double the prior year's loss of $48,407, despite a 268% surge in net revenue to $47,763. The company's cash position deteriorated to zero, and it remains dependent on director loans and equity issuances to fund operations, with an accumulated deficit of $198,267.

• · Operating loss widened to $106,351 in FY2026 from $48,367 in FY2025.
• · Direct operating costs surged to $102,509 from $16,133, while depreciation and amortization rose to $30,605 from $26,200.
• · Net cash used in operating activities increased to $89,641 from $37,332.
• · The company issued 2,019,800 new common shares during FY2026, raising $50,494 in total (par value and additional paid-in capital).
• · Loan from director increased by $55,887 during FY2026, reaching $217,878.
• · Intangible assets (website development) net book value decreased to $97,296 from $100,001, with additional purchases of $27,900.
• · Deferred revenue declined to zero from $7,075, indicating no advance customer payments at year-end.

22-09-2026

AYTU Biopharma's fiscal 2026 annual report (10-K) shows net revenue declined 13.3% YoY to $57.6M, driven by a 20.4% drop in the ADHD portfolio and a 41.4% decline in the pediatric portfolio. The company posted a net loss of $14.3M, slightly wider than the $13.6M loss in fiscal 2025. While the newly launched EXXUA product contributed $6.6M in revenue, it was not enough to offset declines in legacy products. The company remains heavily dependent on five customers for the majority of gross revenue and accounts receivable, and has not achieved sustained profitability.

• · The company faces litigation risks from stockholder derivative and class-action lawsuits.
• · Five significant customers accounted for the great majority of gross revenue and accounts receivable in fiscal 2026.
• · Selling and marketing expenses increased 11.8% YoY to $23.4M, while general and administrative expenses rose 10.9% to $19.3M.
• · Research and development spending was reduced to zero in fiscal 2026 from $1.3M in fiscal 2025.
• · Interest expense decreased 48.8% YoY to $1.9M.
• · Derivative warrant liabilities loss widened to $4.7M from $1.7M in the prior year.
• · The company had no restructuring costs or impairment expense in fiscal 2026, compared to $2.1M and $8.3M respectively in fiscal 2025.
• · Net income from discontinued operations was zero in fiscal 2026 versus $0.6M in fiscal 2025.

22-09-2026

For the three months ended July 31, 2026, AIRWA INC. reported revenue of $21.2M, a 608% increase from $3.0M in the prior-year period, driven by the acquisition of Best Life and its e-commerce operations. However, the company swung to a net loss of $507,193 attributable to controlling interest, compared to net income of $882,652 in Q3 2025, as operating expenses surged to $5.9M from $0.8M and gross profit margin compressed to 26.5% from 75.2%. Cash used in investing activities of $29.4M for subsidiary acquisitions was partially offset by $27.7M in operating cash flow, leaving cash at $11.1M.

• · Gross profit margin declined sharply from 75.2% in Q3 2025 to 26.5% in Q3 2026.
• · Selling and marketing expenses were nil in Q3 2025 but rose to $450,995 in Q3 2026.
• · General and administrative expenses increased 618% YoY to $5.5M.
• · The company recorded a deferred tax benefit of $1.1M in Q3 2026, compared to none in the prior year.
• · Amortization expense on intangible assets was $5.5M in Q3 2026 vs. $0.7M in Q3 2025.
• · Digital assets contributed a $19.0M positive cash flow change in Q3 2026.
• · Accounts receivable provided $11.2M in operating cash flow in Q3 2026, compared to a $3.0M use in Q3 2025.
• · Contract liabilities decreased by $5.0M in Q3 2026.
• · The company acquired non-controlling interest for $2.2M during Q3 2026.
• · Weighted average shares outstanding surged from 364 to 52,678, reflecting significant equity issuance.

22-09-2026

AURA SYSTEMS INC (AUSI) filed its 10-Q for the quarter ended May 31, 2026, reporting a net loss of $8,408 (thousands) compared to a net loss of $2,841 (thousands) in the same quarter last year, a 196% increase in losses. Revenue collapsed 99% to $2 (thousands) from $185 (thousands) in the prior-year period, while total liabilities rose to $54,749 (thousands) from $46,169 (thousands) and shareholders' deficit deepened to $(53,566) (thousands) from $(44,806) (thousands). The company's cash position improved slightly to $27 (thousands) from $11 (thousands) at year-end, but the derivative liability surged to $31,023 (thousands) from $22,844 (thousands).

• · Revenue dropped to essentially zero ($2,000) from $185,000 in the prior-year quarter, a 99% decline.
• · Net loss widened to $8,408,000 from $2,841,000, driven by a $7,028,000 change in fair value of derivative liability (vs. $1,570,000 last year).
• · Total liabilities increased to $54,749,000 from $46,169,000, while total assets fell to $1,183,000 from $1,363,000.
• · Shareholders' deficit grew to $(53,566,000) from $(44,806,000).
• · Derivative liability surged to $31,023,000 from $22,844,000, a 36% increase.
• · Cash used in operating activities improved slightly to $719,000 from $746,000.
• · The company issued 6,860,000 common shares for $751,000 in Q1 FY26, compared to 3,415,152 shares for $848,000 in Q1 FY25.
• · Convertible notes payable to related parties (including past due amounts) total $12,279,000; the Kopple note is $9,259,000 and matures in June 2029.
• · A $20,000 convertible note payable to a Director is past due.
• · Stock options outstanding: 4,000,000 at $0.50 exercise price, all exercisable.
• · No revenue from cost of goods sold in Q1 FY26 (vs. $25,000 in Q1 FY25).
• · Interest expense net was $480,000 (including $385,000 to related parties), down from $594,000 last year.

22-09-2026

Adobe reported strong Q3 FY2026 results with total revenue of $6,760M, up 12.9% YoY, and net income of $2,357M, up 7.8% YoY. However, the company repurchased $6,880M of common stock during the nine months, increasing treasury stock to $55,619M, and total liabilities rose to $18,217M. While subscription revenue grew 13.7% YoY, services and other revenue declined 13.9% YoY in the quarter.

• · Total assets increased to $29,981M at August 28, 2026 from $29,496M at November 28, 2025.
• · Total liabilities rose to $18,217M from $17,873M over the same period.
• · Treasury stock repurchases totaled $6,880M during the nine months ended August 28, 2026.
• · Diluted net income per share for the nine months ended August 28, 2026 was $13.47, up from $12.26 in the prior year period.
• · Other comprehensive income (loss) was $42M for the nine months ended August 28, 2026, compared to $(140)M in the prior year period.